Studies with {? 2}-adrenoceptor agonists and alcohol abstinence syndrome in rats
The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Abstract
Various alpha 2-adrenoceptor agonists were assessed for their effects on alcohol abstinence syndrome in rats. In the first experimental model, groups of Wistar rats were made alcohol dependent by feeding alcohol together with sweetened milk for 15 days. The volume of fluid intake was measured every 12 h to determine daily ethanol consumption. Abstinence signs following abrupt alcohol withdrawal were observed in control as well as test groups receiving various alpha 2-adrenoceptor agonists. Clonidine, guanfacine and B-HT 920, in equimolar concentration (0.5 microM/kg), effectively attenuated the various abstinence signs, which developed after alcohol withdrawal. In the other experimental model, rats were subjected to cold water immersion to induce wet shakes. The inhibitory action of alpha 2-adrenoceptor agonists was assessed in this test model. Clonidine, guanfacine and B-HT 920 markedly suppressed the cold water immersion-induced wet shakes and pretreatment with yohimbine (0.1 and 2.0 microM/kg) reversed this inhibitory effect. The present data reveal the possible therapeutic potential of alpha 2-adrenoceptor agonists in alleviating alcohol abstinence syndrome, and suggest that the resultant reduced noradrenergic activity may be responsible for the beneficial action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Preferential blockade of presynaptic α-adrenoceptors by yohimbine
Starke, K., Borowski, E., & Endo, T. (1975) · European Journal of Pharmacology · doi:10.1016/0014-2999(75)90268-x · Cited by 458
Tolerance to and physical dependence on morphine in rats
Martin, W. R., Wikler, A., Eades, C. G., & Pescor, F. T. (1963) · Psychopharmacologia · doi:10.1007/bf00408180 · Cited by 446
And�n, N.-E., Grabowska, M., & Str�mbom, U. (1976) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00506488 · Cited by 378 · cited 1×
“1972) and noradrenergic (Anden et al. 1976) mechanisms have all been implicated in the above action of clonidine.”
BackgroundCLONIDINE IN OPIATE WITHDRAWAL
Gold, M., Redmond, D. E., & Kleber, H. D. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90699-2 · Cited by 272
α2‐ADRENOCEPTORS MEDIATE CLONIDINE‐INDUCED SEDATION IN THE RAT
DREW, G. M., GOWER, A. J., & MARRIOTT, A. S. (1979) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1979.tb16116.x · Cited by 250 · cited 1×
“Clonidine, in particular, has been reported to produce sedation in rats (Drew et al. 1979), mydriasis in cats (Koss 1981) and hypothermia in rats (Kulkarni 1980), and to possess antiwithdrawal activity against the opiate withdrawal syndrome in human volunteers (Gold et al.”
BackgroundIMMUNOLOGICAL FEATURES OF WEGENER'S GRANULOMATOSIS
Shillitoe, E. J., Lehner, T., Lessof, M. H., & Harrison, D. F. N. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90377-8 · Cited by 239
CLONIDINE IN ALCOHOL WITHDRAWAL
Björkqvist, S. E. (1975) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1975.tb00041.x · Cited by 135
Kobinger, W., & Pichler, L. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90232-6 · Cited by 135 · cited 1×
“1983) and B-HT 920 (Kobinger and Pichler 1981 ; Mottram 1983), were used in addition to clonidine.”
MethodEfficacy of clonidine in treatment of alcohol withdrawal state
Wilkins, A., Jenkins, W. J., & Steiner, J. A. (1983) · Psychopharmacology · doi:10.1007/bf00439278 · Cited by 94
Clonidine treatment of schizophrenia: DOUBLE‐BLIND COMPARISON TO PLACEBO AND NEUROLEPTIC DRUGS
Freedman, R., Kirch, D., Bell, J., Adler, L. E., Pecevich, M., Pachtman, E., & Denver, P. (1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb00819.x · Cited by 91 · cited 1×
“Fur thermore, some prel iminary evidence has accumulated indicating that manifestat ions of the abstinence syndrome are mediated by hyperactivi ty of catecholamines in man (Freedman et al. 1982).”
Background
Research works printed but not linked: 1
- Dausse JP, Cardot A, Meyer P (1983) Specific binding of3H-guanfacine to alpha2 adrenceptors in rat brain: comparison with clonidine. J Pharmacol Paris 14:35?46
Cited by
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
“Subsequent studies have shown that a2-adrenergic agonists decrease somatic signs of alcohol withdrawal in animal models (Parale and Kulkarni, 1986; Riihioja et al., 1997), including responses that are associated with hyperkatifeia, such as the clonidine-induced blockade of anxiogenic-like effects…”
BackgroundTicku, M. K., & Kulkarni, S. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90487-x · Cited by 136
Self-citationThe pharmacological importance of agmatine in the brain
Uzbay, T. I. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.08.006 · Cited by 127
Maldonado, J. R. (2017) · Critical Care Clinics · doi:10.1016/j.ccc.2017.03.012 · Cited by 109
Uzbay, T. I. (1995) · Pharmacological Research · doi:10.1016/1043-6618(95)80045-x · Cited by 97
Effects of agmatine on ethanol withdrawal syndrome in rats
Uzbay, T. I., Yeşilyurt, Ö., Çelik, T., Ergün, H., & Işimer, A. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00127-8 · Cited by 97
Neuroprotective Role of Agmatine in Neurological Diseases
Xu, W., Gao, L., Li, T., Shao, A., & Zhang, J. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170808120633 · Cited by 87
Taksande, B. G., Kotagale, N. R., Patel, M. R., Shelkar, G. P., Ugale, R. R., & Chopde, C. T. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.058 · Cited by 85
“This effect of imidazoline receptor agonists on ethanol withdrawal anxiety is also supported by various preclinical studies (Mao and Abdel-Rahman, 1996; Opitz, 1990; Parale and Kulkarni, 1986; Vandergriff et al., 2000).”
BackgroundMethodIncreasing treatment options for cannabis dependence: A review of potential pharmacotherapies
Hart, C. L. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.03.027 · Cited by 83
Protective Effect of Quercetin on Alcohol Abstinence-Induced Anxiety and Convulsions
Joshi, D., Naidu, P. S., Singh, A., & Kulkarni, S. (2005) · Journal of Medicinal Food · doi:10.1089/jmf.2005.8.392 · Cited by 47
Self-citationEffects of fluoxetine on ethanol withdrawal syndrome in rats
Uzbay, T. I., lam, E. S., Kayır, H., Çelik, T., & Beyazyürek, M. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2003.11.007 · Cited by 47
Fox, H., & Sinha, R. (2014) · Advances in Pharmacology · doi:10.1016/b978-0-12-420118-7.00006-8 · Cited by 46
“…that both clonidine and guanfacine were able to reduce ethanol intake in ethanol-preferring rats having free choice between 10% ethanol or water (Opitz, 1990) as well as attenuate the appearance and incidence of ethanol withdrawal symptoms (Parale & Kulkarni, 1986; Washton & Resnick, 1981).”
BackgroundDhir, A., Naidu, P. S., & Kulkarni, S. (2005) · Addiction Biology · doi:10.1080/13556210500352964 · Cited by 41
“The withdrawal symptoms, well characterized in humans (Parale & Kulkarni, 1986), consist of an early (tremor, diaphoresis, hallucinations, convulsions) and delayed (delirium, tremors, increased autonomic activity, profound sweating and profound disorientation) reaction.”
BackgroundSelf-citationAlcohol Withdrawal Syndrome: Clinical and Hormonal Responses to α2‐Adrenergic Agonist Treatment
Cushman, P., & Sowers, J. R. (1989) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1989.tb00336.x · Cited by 39
Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats
Uzbay, T. I., Akarsu, E. S., & Kayaalp, S. O. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90251-8 · Cited by 35
Pharmacotherapy and Pathophysiology of Alcohol Withdrawal
Anton, R. F., & Becker, H. C. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-78435-4_13 · Cited by 38
The effect of clonidine and related substances on voluntary ethanol consumption in rats
Opitz, K. (1990) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(90)90139-6 · Cited by 31
Rafi, H., Rafiq, H., & Farhan, M. (2021) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-021-00125-8 · Cited by 28
“Binding abilities of agmatine to α2-adrenoceptors inhibited withdrawal syndrome similar to clonidine which produces same inhibitory effects in rats [28].”
BackgroundATTENUATION OF ETHANOL WITHDRAWAL SIGNS BY HIGH DOSES OF L-ARGININE IN RATS
Uzbay, T. I., & Erden, B. F. (2003) · Alcohol and Alcoholism · doi:10.1093/alcalc/agg075 · Cited by 26
Agmatine Inhibits Behavioral Sensitization to Ethanol Through Imidazoline Receptors
Taksande, B. G., Khade, S. D., Aglawe, M. M., Gujar, S., Chopde, C. T., & Kotagale, N. R. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13972 · Cited by 18
“This effect of imidazoline receptor agents on EtOH sensitization is also supported by various preclinical studies (Mao and AbdelRahman, 1996; Opitz, 1990; Parale and Kulkarni, 1986; Vandergriff et al., 2000).”
BackgroundEffects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats
Celikyurt, I. K., Kayır, H., Ulak, G., Erden, F. B., Ulusoy, K. G., & Uzbay, T. I. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.009 · Cited by 17
“Even a slight body weight loss in the rats fed with an ethanolcontaining liquid diet can be accepted as normal (Parale and Kulkarni, 1986; LarueAchagiotis et al., 1990; Uzbay and Kayaalp, 1995).”
Effects of Clozapine on Ethanol Withdrawal Syndrome in Rats
Kayır, H., & Uzbay, T. I. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn052 · Cited by 16
Curley, D. E., Vasaturo-Kolodner, T. R., Cannella, N., Ciccocioppo, R., & Haass‐Koffler, C. L. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01363-9 · Cited by 15
Sex-related effects of agmatine on caffeine-induced locomotor activity in Swiss Webster mice
Uzbay, T. I., Kose, A., Kayır, H., Ulusoy, K. G., & Çelik, T. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.12.020 · Cited by 15
Taksande, B. G., Nambiar, S., Patil, S., Umekar, M. J., Aglawe, M. M., & Kotagale, N. R. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172779 · Cited by 14
Effects of α2‐Adrenergic Drugs on the Alcohol Consumption of Alcohol‐Preferring Rats
Korpi, E. R. (1990) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1990.tb00748.x · Cited by 9
Investigation of the effects of moclobemide in chronic ethanol feeding rats
Uzbay, T. I., SEVER, B., Çelik, T., & Ayhan, I. H. (1995) · Pharmacological Research · doi:10.1016/s1043-6618(05)80016-7 · Cited by 9
Barajaz, A. M., & Kliethermes, C. L. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.09.022 · Cited by 5
Adenosinergic System: An Assorted Approach To Therapeutics For Drug Addiction
Akula, K. K., & Sk, K. (2012) · Future Neurology · doi:10.2217/fnl.12.19 · Cited by 5
Novel pharmacotherapies and patents for alcohol abuse and alcoholism 1998-2001
Agabio, R., Colombo, G., Carai, M. A. M., & Gessa, G. L. (2001) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.11.10.1497 · Cited by 4
Pathophysiologie der Alkoholpsychosen
Soyka, M. (1993) · Springer eBooks · doi:10.1007/978-3-642-84961-9_6 · Cited by 3
Alpha-2 Adrenergic Agonists Reduce Heavy Alcohol Drinking and Improve Cognitive Performance in Mice
Quadir, S. G., Lepeak, L., Miracle, S. A., Collu, R., Velte, O., He, Y., Öztürk, Z., Rohl, C. D., Sabino, V., & Cottone, P. (2026) · eNeuro · doi:10.1523/eneuro.0368-25.2026 · Cited by 1
Liquid Diet for Administering Alcohol
Uzbay, T. I., & Bizarro, L. (2014) · Springer eBooks · doi:10.1007/978-3-642-27772-6_153-2 · Cited by 1
Liquid Diet for Administering Alcohol
Uzbay, T., & Bizarro, L. (2010) · Springer eBooks · doi:10.1007/978-3-540-68706-1_153 · Cited by 1
The effect of moclobemide, reversible inhibitor of monoamine oxidase-A, on the ethanolized rat brain
Karaöz, E., Kanter, M., Başçi, Z., & KÖKSAL, V. (2013) · DergiPark (Istanbul University)
Potential Pharmacotherapies for Cannabis Dependence
Hart, C. L., & Shytle, R. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_53
Liquid Diet for Administering Alcohol
Uzbay, T. I., & Bizarro, L. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_153
Metadata
- Authors
- Parale, M. P., & Kulkarni, S. K.
- Affiliations
- Panjab University (IN)
- ORCID
- Kulkarni, S. K.
- Venue
- Psychopharmacology
- Published
- 1986
- Volume
- 88
- Issue
- 2
- Pages
- 237-239
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1988478202
- Cited by
- 38
- References
- 26
- Citations by year
- 2026: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2017: 3 · 2015: 1 · 2014: 2 · 2013: 1 · 2012: 1
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- alpha-2 adrenergic agonists, alcohol withdrawal, clonidine, guanfacine, B-HT 920, yohimbine, cold water immersion, noradrenergic activity, alcoholism, ethanol consumption
- MeSH terms
- Adrenergic alpha-Agonists, Ethanol, Animals, Azepines, Clonidine, Guanidines, Male, Phenylacetates, Rats, Inbred Strains, Substance Withdrawal Syndrome, Guanfacine, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.